Tempest Therapeutics

San Francisco, United States

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

May 2026

Post-IPO Equity

Biotechnology Health Care Therapeutics

Top Investors

Lilly Asia VenturesForesite CapitalNew Enterprise AssociatesQuan CapitalVersant Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tempest Therapeutics

Who are Tempest Therapeutics's investors?

Tempest Therapeutics's investors include Lilly Asia Ventures, Foresite Capital, New Enterprise Associates, Quan Capital, Versant Ventures.

Where is Tempest Therapeutics headquartered?

Tempest Therapeutics is headquartered in San Francisco, United States.

What does Tempest Therapeutics do?

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

What stage is Tempest Therapeutics at?

Tempest Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 29, 2026.

MLA

"Tempest Therapeutics — Funding & Investors." VCBacked, May 29, 2026, https://www.vcbacked.co/company/tempest-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Tempest Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/tempest-therapeutics

Wikipedia (cite web)

{{cite web |title=Tempest Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tempest-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 29, 2026.

Similar Companies in Biotechnology